-+ 0.00%
-+ 0.00%
-+ 0.00%

*Edgewise Therapeutics Completes Sale of Sevasemten for Up to $2.65B, Strengthening Balance Sheet and Centering Co Focus on Cardiovascular Pipeline

Dow Jones·07/13/2026 12:31:00

登录查看新闻详情